Product image of Lindynette (Ethinylestradiol, Gestodene) supplied by GNH India

Lindynette

Active Ingredient:
Ethinylestradiol, Gestodene
Origin:
EU

Lindynette (Ethinylestradiol, Gestodene)

Ethinylestradiol / Gestodene, the active ingredient in Lindynette, is a combined oral contraceptive presented as an oral tablet for oral use. It provides hormonal contraception to prevent pregnancy in women of reproductive age by suppressing ovulation and altering cervical mucus.

GNH India supplies Lindynette as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across EU and global markets. The product meets EU pharmacopoeia standards and is manufactured under GMP conditions.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lindynette, a combined oral contraceptive, is indicated for hormonal contraception and related menstrual management.

  • Prevention of pregnancy: provides effective contraception for women of childbearing potential.
  • Regulation of menstrual cycles: helps achieve more predictable bleeding patterns and reduces menstrual flow.
  • Management of dysmenorrhea: alleviates painful menstrual cramps associated with ovulatory cycles.

How It Works

  • Ethinylestradiol and gestodene act together to suppress the mid‑cycle surge of luteinising hormone and follicle‑stimulating hormone, thereby inhibiting ovulation. The estrogen component stabilises the endometrial lining, while the progestogen thickens cervical mucus and induces endometrial changes that reduce the likelihood of implantation.

Side Effects

Lindynette may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects

  • Nausea: mild to moderate stomach upset, often transient.
  • Breast tenderness: discomfort or swelling of the breasts.
  • Headache: mild to moderate intensity, may improve with continued use.
  • Spotting or breakthrough bleeding: irregular light bleeding between periods.
  • Weight fluctuation: modest changes in fluid retention.
  • Mood changes: irritability or mild mood swings.

Serious or Rare Side Effects

  • Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism.
  • Arterial thrombosis: stroke or myocardial infarction.
  • Severe hypertension: sudden increase in blood pressure.
  • Liver dysfunction: jaundice or hepatic adenoma.
  • Allergic reactions: rash, angioedema, or anaphylaxis.

Precautions & Warnings

Before prescribing Lindynette, consider the following precautions and warnings.

  • Contraindicated in pregnancy: avoid use in women who are or may become pregnant.
  • Smoking over age 35: increased risk of cardiovascular events; advise cessation.
  • History of thromboembolism: avoid in patients with prior clotting disorders.
  • Liver disease: use with caution in hepatic impairment.
  • Hypertension: monitor blood pressure regularly.
  • Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Lindynette can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Enzyme inducers (e.g., rifampin, phenytoin, carbamazepine, St. John's wort): may reduce contraceptive effectiveness.
  • Anticoagulants (e.g., warfarin): hormonal component can alter INR levels.
  • Certain HIV protease inhibitors: may increase hormone concentrations, raising risk of side effects.

Moderate Interactions (Monitor Closely)

  • Antidepressants (SSRIs): may increase risk of mood changes.
  • Antihypertensives: possible reduction in blood‑pressure control.
  • Digoxin: slight increase in serum levels.
  • Anticonvulsants (valproate): may affect hormone metabolism.
  • Antibiotics (macrolides, tetracyclines): generally safe but monitor for breakthrough bleeding.

Frequently Asked Questions

Lindynette is a combined oral contraceptive indicated primarily for the prevention of pregnancy in women of reproductive age. It is also prescribed to help regulate menstrual cycles and to reduce menstrual‑related symptoms such as heavy bleeding and painful cramps.

The estrogen component, ethinylestradiol, and the progestogen gestodene work together to inhibit the mid‑cycle surge of luteinising hormone and follicle‑stimulating hormone, preventing ovulation. Additionally, gestodene thickens cervical mucus and alters the endometrial lining, creating an environment that is unfavorable for fertilisation and implantation.

The dosing regimen for Lindynette is determined by the prescribing healthcare professional. Typically, it involves a daily oral tablet taken at the same time each day for a specified cycle, followed by a hormone‑free interval, but the exact schedule should be confirmed with the prescriber.

Lindynette is classified as pregnancy category X, meaning it must not be used during pregnancy because it can harm the fetus. It is also not recommended for breastfeeding women, as hormonal exposure may affect milk production and infant development.

To order Lindynette, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Lindynette contains ethinylestradiol combined with gestodene, a third‑generation progestogen that offers a favorable bleeding profile and lower androgenic activity compared with some older formulations. Its efficacy in preventing pregnancy is comparable to other combined pills, while the side‑effect spectrum may differ slightly based on the specific progestogen used.

Lindynette tablets should be stored at room temperature, below 25 °C (77 °F). Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure they are out of reach of children.

Lindynette is taken orally, once daily, at the same time each day. The tablet is swallowed with water and should be started on the first day of the menstrual period or as directed by a healthcare professional.

The most serious risks include venous thromboembolism (deep‑vein thrombosis or pulmonary embolism), arterial thrombosis (stroke or heart attack), severe hypertension, and rare liver disorders. Patients should seek immediate medical attention if they experience unexplained chest pain, shortness of breath, severe headache, visual changes, or sudden swelling of the legs.

Lindynette should not be used by women who are pregnant, have a known or suspected pregnancy, have a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, breast cancer, or who are smokers over the age of 35. It is also contraindicated in individuals with known hypersensitivity to any component of the product.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Gestodene

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT